September 23, 2017 3:00 AM ET


Company Overview of Virobay Inc.

Key Executives for Virobay Inc.

NameBoard RelationshipsTitleAge
Robert F. G. Booth Ph.D.45 RelationshipsCo-Founder, Chairman, Chief Executive Officer, President and Secretary63
Heather Preston M.D.36 RelationshipsCo-Founder and Director51
Kyle C. Elrod B.A.No RelationshipsSenior Vice President of Project Management and Operations50
Elizabeth G. Shigezumi No RelationshipsHead of Clinical Operations and Clinical Trial Manager of Clinical Operations58

Virobay Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Robert F. G. Booth Ph.D. 45 RelationshipsVirobay Inc.63
Heather Preston M.D. 36 RelationshipsVirobay Inc.51
Thomas John Dietz Ph.D. 82 RelationshipsEiger BioPharmaceuticals, Inc.53
Daniel S. Janney MBA 78 RelationshipsAlta Partners LP52
Jeffrey W. Bird M.D., Ph.D. 91 RelationshipsVerinata Health, Inc.57
View All Board Members

Virobay Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Ph.D.Thomas John Dietz82 Relationships3 Executives
Compensation Committee Ph.D.Thomas John Dietz82 Relationships3 Executives
Nominating Committee M.D.Heather Preston36 Relationships3 Executives
Corporate Governance Committee M.D.Heather Preston36 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation
Not meaningful
Total Value of Options$355.4K
Compensation as of Fiscal Year 2013
Virobay Inc. CEO Compensation
Industry Average


Calithera Biosciences Appoints Blake Wise to Board of Directors
September 21, 2017 8:05 PM ET
Adamas Pharmaceuticals, Inc. Announces Management Changes
September 21, 2017 8:05 PM ET
Insys Therapeutics, Inc. Hires Joe McGrath as Senior Director of Corporate Communications
September 21, 2017 8:01 PM ET
Medicenna Therapeutics Corp. Appoints William Li to its Board of Directors
September 21, 2017 8:00 PM ET
AIVITA Biomedical Appoints Michael H. Gold to Scientific Advisory Board
September 21, 2017 4:20 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Virobay Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at